Clinical Practice Guideline for Diagnosis and Management of Faltering Weight

Hans B Kersten1, Praveen S Goday2, Ruba Abdelhadi3

  • 1St. Christopher's Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania.

Pediatrics
|March 15, 2026
PubMed

Insights

This guideline updates "failure to thrive" to "faltering weight" using z scores for diagnosis. It recommends increased calories, nutritional support, and feeding therapy for children with poor weight gain.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Practice Guidelines
  • Child Health

Background:

  • The term "failure to thrive" is being updated to "faltering weight" in pediatric care.
  • Current diagnostic criteria for poor weight gain lack standardization, leading to confusion.
  • Healthcare providers need updated guidance for managing children with inadequate weight gain.

Purpose of the Study:

  • To provide an evidence-based clinical practice guideline for diagnosing and managing children with faltering weight.
  • To update diagnostic criteria using z scores instead of percentiles.
  • To offer recommendations for nutritional support and therapy.

Main Methods:

  • Development of a clinical practice guideline (CPG) by expert panels from the American Academy of Pediatrics and NASPGHAN.
  • Utilized the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach for evidence synthesis and recommendation formulation.
  • Consensus-based decision-making through iterative discussion and voting.

Main Results:

  • Introduced "faltering weight" as the updated term, defined by specific z score cutoffs for weight-for-length, BMI-for-age, and weight gain velocity.
  • Provided 8 Key Action Statements and 4 Good Practice Statements for clinical management.
  • Recommended increased caloric intake, oral nutritional supplementation, and pediatric feeding disorder therapy.

Conclusions:

  • The guideline aims to reduce diagnostic confusion and improve accuracy in identifying children with faltering weight.
  • It seeks to decrease unnecessary laboratory and imaging tests in children with poor weight gain.
  • Implementation is expected to enhance healthcare utilization and outcomes for children experiencing faltering weight.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K